

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.18968841 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.00008369 |
| 3 | fatty acid elongation (GO:0030497) | 5.86249463 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 5.83121515 |
| 5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.83121515 |
| 6 | axon ensheathment in central nervous system (GO:0032291) | 5.72146591 |
| 7 | central nervous system myelination (GO:0022010) | 5.72146591 |
| 8 | respiratory electron transport chain (GO:0022904) | 5.28697638 |
| 9 | electron transport chain (GO:0022900) | 5.15063476 |
| 10 | protein neddylation (GO:0045116) | 5.06988062 |
| 11 | DNA deamination (GO:0045006) | 4.84222891 |
| 12 | chaperone-mediated protein transport (GO:0072321) | 4.68462769 |
| 13 | NADH dehydrogenase complex assembly (GO:0010257) | 4.27775779 |
| 14 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.27775779 |
| 15 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.27775779 |
| 16 | aldehyde catabolic process (GO:0046185) | 4.17749811 |
| 17 | cholesterol biosynthetic process (GO:0006695) | 4.11454852 |
| 18 | signal peptide processing (GO:0006465) | 4.01923396 |
| 19 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.97821695 |
| 20 | protein complex biogenesis (GO:0070271) | 3.96486723 |
| 21 | cytidine metabolic process (GO:0046087) | 3.70424521 |
| 22 | cytidine catabolic process (GO:0006216) | 3.70424521 |
| 23 | cytidine deamination (GO:0009972) | 3.70424521 |
| 24 | mannosylation (GO:0097502) | 3.63972232 |
| 25 | cytochrome complex assembly (GO:0017004) | 3.61977003 |
| 26 | response to redox state (GO:0051775) | 3.61044189 |
| 27 | sterol biosynthetic process (GO:0016126) | 3.55829939 |
| 28 | GPI anchor biosynthetic process (GO:0006506) | 3.45480991 |
| 29 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.44686714 |
| 30 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.43764005 |
| 31 | substantia nigra development (GO:0021762) | 3.43498641 |
| 32 | nucleotide transmembrane transport (GO:1901679) | 3.34233964 |
| 33 | myelination (GO:0042552) | 3.31332166 |
| 34 | amyloid precursor protein metabolic process (GO:0042982) | 3.29076590 |
| 35 | isoprenoid biosynthetic process (GO:0008299) | 3.28988185 |
| 36 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.28764612 |
| 37 | amyloid precursor protein catabolic process (GO:0042987) | 3.28584302 |
| 38 | axon ensheathment (GO:0008366) | 3.27831675 |
| 39 | ensheathment of neurons (GO:0007272) | 3.27831675 |
| 40 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.23259609 |
| 41 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.22798378 |
| 42 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.21908683 |
| 43 | cofactor catabolic process (GO:0051187) | 3.19062063 |
| 44 | L-phenylalanine catabolic process (GO:0006559) | 3.15001530 |
| 45 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.15001530 |
| 46 | GPI anchor metabolic process (GO:0006505) | 3.10795127 |
| 47 | hydrogen ion transmembrane transport (GO:1902600) | 3.10430335 |
| 48 | ribonucleoprotein complex disassembly (GO:0032988) | 3.09600081 |
| 49 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.03901580 |
| 50 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.03901580 |
| 51 | neutrophil activation involved in immune response (GO:0002283) | 3.01394100 |
| 52 | regulation of interleukin-8 secretion (GO:2000482) | 3.00717546 |
| 53 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.97228748 |
| 54 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.96244537 |
| 55 | succinate metabolic process (GO:0006105) | 2.96223787 |
| 56 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.95877505 |
| 57 | respiratory chain complex IV assembly (GO:0008535) | 2.95147255 |
| 58 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.94348598 |
| 59 | proton transport (GO:0015992) | 2.94291200 |
| 60 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.93817330 |
| 61 | anterograde synaptic vesicle transport (GO:0048490) | 2.92172847 |
| 62 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.90132187 |
| 63 | response to methylmercury (GO:0051597) | 2.89865782 |
| 64 | hydrogen transport (GO:0006818) | 2.88383939 |
| 65 | actin nucleation (GO:0045010) | 2.88202099 |
| 66 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.86397624 |
| 67 | axoneme assembly (GO:0035082) | 2.85313631 |
| 68 | negative regulation of protein localization to cell surface (GO:2000009) | 2.84479500 |
| 69 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.84170931 |
| 70 | positive regulation of B cell differentiation (GO:0045579) | 2.83705284 |
| 71 | negative regulation of neurotransmitter transport (GO:0051589) | 2.83209663 |
| 72 | platelet dense granule organization (GO:0060155) | 2.81720384 |
| 73 | organelle disassembly (GO:1903008) | 2.80080592 |
| 74 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.78562363 |
| 75 | positive regulation of mitochondrial fission (GO:0090141) | 2.77562074 |
| 76 | regulation of collateral sprouting (GO:0048670) | 2.76748765 |
| 77 | regulation of metalloenzyme activity (GO:0048552) | 2.76311779 |
| 78 | base-excision repair, AP site formation (GO:0006285) | 2.73807856 |
| 79 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.73757752 |
| 80 | glycerophospholipid catabolic process (GO:0046475) | 2.72970599 |
| 81 | adhesion of symbiont to host cell (GO:0044650) | 2.72341479 |
| 82 | virion attachment to host cell (GO:0019062) | 2.72341479 |
| 83 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.71719963 |
| 84 | aerobic respiration (GO:0009060) | 2.71420059 |
| 85 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.71213448 |
| 86 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.70727807 |
| 87 | L-phenylalanine metabolic process (GO:0006558) | 2.70727807 |
| 88 | ATP biosynthetic process (GO:0006754) | 2.69724736 |
| 89 | proteasome assembly (GO:0043248) | 2.69237934 |
| 90 | piRNA metabolic process (GO:0034587) | 2.68554788 |
| 91 | peroxisome fission (GO:0016559) | 2.68257709 |
| 92 | membrane budding (GO:0006900) | 2.67118476 |
| 93 | C-terminal protein lipidation (GO:0006501) | 2.65491418 |
| 94 | glutathione biosynthetic process (GO:0006750) | 2.64763013 |
| 95 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.63385658 |
| 96 | very long-chain fatty acid metabolic process (GO:0000038) | 2.63135282 |
| 97 | inositol phosphate catabolic process (GO:0071545) | 2.61909545 |
| 98 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.60907516 |
| 99 | adenosine metabolic process (GO:0046085) | 2.60722664 |
| 100 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.60602729 |
| 101 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.57741797 |
| 102 | dopamine transport (GO:0015872) | 2.57669701 |
| 103 | deoxyribose phosphate catabolic process (GO:0046386) | 2.56728271 |
| 104 | regulation of cellular amine metabolic process (GO:0033238) | 2.56276138 |
| 105 | cellular response to interferon-beta (GO:0035458) | 2.55952583 |
| 106 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.55814206 |
| 107 | inositol phosphate dephosphorylation (GO:0046855) | 2.55814206 |
| 108 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.54537803 |
| 109 | glutathione derivative biosynthetic process (GO:1901687) | 2.54283118 |
| 110 | glutathione derivative metabolic process (GO:1901685) | 2.54283118 |
| 111 | creatine metabolic process (GO:0006600) | 2.54125838 |
| 112 | opsonization (GO:0008228) | 2.53713154 |
| 113 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.53679191 |
| 114 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.53315766 |
| 115 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.52769236 |
| 116 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.52769236 |
| 117 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.52566509 |
| 118 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.52535028 |
| 119 | cullin deneddylation (GO:0010388) | 2.52205648 |
| 120 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.50734528 |
| 121 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.50734528 |
| 122 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.50734528 |
| 123 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.50254020 |
| 124 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.50207941 |
| 125 | deoxyribose phosphate metabolic process (GO:0019692) | 2.49455503 |
| 126 | metallo-sulfur cluster assembly (GO:0031163) | 2.49455073 |
| 127 | iron-sulfur cluster assembly (GO:0016226) | 2.49455073 |
| 128 | positive regulation of protein homodimerization activity (GO:0090073) | 2.49122273 |
| 129 | immunoglobulin mediated immune response (GO:0016064) | 2.48621887 |
| 130 | coenzyme catabolic process (GO:0009109) | 2.48473010 |
| 131 | oxidative phosphorylation (GO:0006119) | 2.48444881 |
| 132 | regulation of catecholamine metabolic process (GO:0042069) | 2.48425271 |
| 133 | regulation of dopamine metabolic process (GO:0042053) | 2.48425271 |
| 134 | protein deneddylation (GO:0000338) | 2.48069362 |
| 135 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.47866030 |
| 136 | glycolipid biosynthetic process (GO:0009247) | 2.47380708 |
| 137 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.47335858 |
| 138 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.47335858 |
| 139 | L-methionine salvage (GO:0071267) | 2.46535890 |
| 140 | L-methionine biosynthetic process (GO:0071265) | 2.46535890 |
| 141 | amino acid salvage (GO:0043102) | 2.46535890 |
| 142 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.46441212 |
| 143 | protein targeting to mitochondrion (GO:0006626) | 2.45948196 |
| 144 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.45706851 |
| 145 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.45338539 |
| 146 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.45188630 |
| 147 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.45166003 |
| 148 | regulation of B cell apoptotic process (GO:0002902) | 2.44133802 |
| 149 | acyl-CoA biosynthetic process (GO:0071616) | 2.44059475 |
| 150 | thioester biosynthetic process (GO:0035384) | 2.44059475 |
| 151 | response to interferon-beta (GO:0035456) | 2.42276758 |
| 152 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.42092473 |
| 153 | regulation of cilium movement (GO:0003352) | 2.40110997 |
| 154 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.38007545 |
| 155 | deoxyribonucleotide catabolic process (GO:0009264) | 2.37932068 |
| 156 | regulation of mitochondrial fission (GO:0090140) | 2.36899457 |
| 157 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.36497276 |
| 158 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.36422791 |
| 159 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.36331118 |
| 160 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.35479982 |
| 161 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.35281398 |
| 162 | regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108) | 2.35046973 |
| 163 | mature B cell differentiation involved in immune response (GO:0002313) | 2.34717583 |
| 164 | response to pheromone (GO:0019236) | 2.34362445 |
| 165 | C-terminal protein amino acid modification (GO:0018410) | 2.33185358 |
| 166 | regulation of hexokinase activity (GO:1903299) | 2.33170235 |
| 167 | regulation of glucokinase activity (GO:0033131) | 2.33170235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.66182671 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.27018910 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.12534114 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.99579485 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.91379629 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.78436916 |
| 7 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.55754830 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.54738823 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.48227667 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.42229860 |
| 11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.30233015 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.21966855 |
| 13 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.20737242 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.17652569 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.10492462 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.08920286 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.08184331 |
| 18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.06179847 |
| 19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.00684213 |
| 20 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.99356953 |
| 21 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.91762221 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.89122755 |
| 23 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86192422 |
| 24 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.74896714 |
| 25 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.74855295 |
| 26 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.71085496 |
| 27 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.71085496 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.67755196 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.67350375 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.66863197 |
| 31 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.59555643 |
| 32 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.56395907 |
| 33 | GATA3_26560356_Chip-Seq_TH2_Human | 1.55554606 |
| 34 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.46828072 |
| 35 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46718385 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.46682977 |
| 37 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.44744876 |
| 38 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.43294075 |
| 39 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.43122735 |
| 40 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.40376743 |
| 41 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.38888152 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.38847996 |
| 43 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.38484752 |
| 44 | FUS_26573619_Chip-Seq_HEK293_Human | 1.37827363 |
| 45 | AR_20517297_ChIP-Seq_VCAP_Human | 1.36718482 |
| 46 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.35219595 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.34850404 |
| 48 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.34288075 |
| 49 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.32421373 |
| 50 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.32076914 |
| 51 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.32076914 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30868013 |
| 53 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.29128223 |
| 54 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.28603169 |
| 55 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.28507682 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.28369939 |
| 57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24328142 |
| 58 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24061882 |
| 59 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.21300168 |
| 60 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.19972954 |
| 61 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.18614703 |
| 62 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.18458429 |
| 63 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.17498033 |
| 64 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.16925189 |
| 65 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.16685545 |
| 66 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.16032945 |
| 67 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.15322506 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.15283471 |
| 69 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.15114259 |
| 70 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.14339888 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.13672631 |
| 72 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.12454886 |
| 73 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12094998 |
| 74 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.11990075 |
| 75 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11614667 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08535917 |
| 77 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07839022 |
| 78 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07839022 |
| 79 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07526441 |
| 80 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.05718344 |
| 81 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.05718344 |
| 82 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.05694978 |
| 83 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04939715 |
| 84 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04793116 |
| 85 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.04509652 |
| 86 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.04281958 |
| 87 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.04021412 |
| 88 | NCOR_22424771_ChIP-Seq_293T_Human | 1.03567178 |
| 89 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.03214300 |
| 90 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.02340209 |
| 91 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.02006533 |
| 92 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.01085094 |
| 93 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.00524056 |
| 94 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99982098 |
| 95 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.99811849 |
| 96 | JUN_21703547_ChIP-Seq_K562_Human | 0.98510711 |
| 97 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.97964219 |
| 98 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.97239241 |
| 99 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.96841884 |
| 100 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.96478069 |
| 101 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.96454725 |
| 102 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96065727 |
| 103 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.96059939 |
| 104 | EWS_26573619_Chip-Seq_HEK293_Human | 0.95978882 |
| 105 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.95534476 |
| 106 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.95256203 |
| 107 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95098408 |
| 108 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94270107 |
| 109 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93942361 |
| 110 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93913155 |
| 111 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.93412126 |
| 112 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.93063490 |
| 113 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92896535 |
| 114 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92749311 |
| 115 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92723532 |
| 116 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.92161878 |
| 117 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92053802 |
| 118 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.90683538 |
| 119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90614820 |
| 120 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.88954961 |
| 121 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.88273551 |
| 122 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.87230417 |
| 123 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.87022849 |
| 124 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.86815153 |
| 125 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.85910497 |
| 126 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.85862305 |
| 127 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85781860 |
| 128 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.85747274 |
| 129 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83160629 |
| 130 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.83070084 |
| 131 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.82798252 |
| 132 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.82794359 |
| 133 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.82002584 |
| 134 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.80793769 |
| 135 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.80455904 |
| 136 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.79553680 |
| 137 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.79146945 |
| 138 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.78087606 |
| 139 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.77174152 |
| 140 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.76973624 |
| 141 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.76855238 |
| 142 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.76727369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 3.77053717 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.61299693 |
| 3 | MP0001905_abnormal_dopamine_level | 3.30653612 |
| 4 | MP0009379_abnormal_foot_pigmentation | 3.11586555 |
| 5 | MP0001529_abnormal_vocalization | 2.80214570 |
| 6 | MP0003880_abnormal_central_pattern | 2.79491052 |
| 7 | MP0003195_calcinosis | 2.61796900 |
| 8 | MP0003329_amyloid_beta_deposits | 2.27064652 |
| 9 | MP0003186_abnormal_redox_activity | 2.20901520 |
| 10 | MP0005645_abnormal_hypothalamus_physiol | 2.12179584 |
| 11 | MP0005409_darkened_coat_color | 2.05160475 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.01269093 |
| 13 | MP0004147_increased_porphyrin_level | 1.98884084 |
| 14 | MP0002876_abnormal_thyroid_physiology | 1.97873793 |
| 15 | MP0005408_hypopigmentation | 1.95521487 |
| 16 | MP0004142_abnormal_muscle_tone | 1.92930060 |
| 17 | MP0000566_synostosis | 1.88979733 |
| 18 | MP0003950_abnormal_plasma_membrane | 1.88281047 |
| 19 | MP0000372_irregular_coat_pigmentation | 1.85136482 |
| 20 | MP0005367_renal/urinary_system_phenotyp | 1.80089913 |
| 21 | MP0000516_abnormal_urinary_system | 1.80089913 |
| 22 | MP0005171_absent_coat_pigmentation | 1.78813586 |
| 23 | MP0006036_abnormal_mitochondrial_physio | 1.74360876 |
| 24 | MP0001800_abnormal_humoral_immune | 1.73577771 |
| 25 | MP0002166_altered_tumor_susceptibility | 1.72912897 |
| 26 | MP0006082_CNS_inflammation | 1.69864851 |
| 27 | MP0009697_abnormal_copulation | 1.69607352 |
| 28 | MP0003690_abnormal_glial_cell | 1.64387818 |
| 29 | MP0005084_abnormal_gallbladder_morpholo | 1.64343180 |
| 30 | MP0008875_abnormal_xenobiotic_pharmacok | 1.62653569 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.62370046 |
| 32 | MP0002139_abnormal_hepatobiliary_system | 1.62123374 |
| 33 | MP0003787_abnormal_imprinting | 1.57548591 |
| 34 | MP0009764_decreased_sensitivity_to | 1.56752096 |
| 35 | MP0003724_increased_susceptibility_to | 1.55393636 |
| 36 | MP0003786_premature_aging | 1.54112742 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.54030592 |
| 38 | MP0000604_amyloidosis | 1.53638742 |
| 39 | MP0002102_abnormal_ear_morphology | 1.52436817 |
| 40 | MP0002295_abnormal_pulmonary_circulatio | 1.52313026 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.51511849 |
| 42 | MP0009785_altered_susceptibility_to | 1.50173591 |
| 43 | MP0006072_abnormal_retinal_apoptosis | 1.48844557 |
| 44 | MP0004145_abnormal_muscle_electrophysio | 1.46881184 |
| 45 | MP0002723_abnormal_immune_serum | 1.44758996 |
| 46 | MP0001986_abnormal_taste_sensitivity | 1.42625255 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.42241540 |
| 48 | MP0005083_abnormal_biliary_tract | 1.38675132 |
| 49 | MP0004043_abnormal_pH_regulation | 1.38621870 |
| 50 | MP0001853_heart_inflammation | 1.37732248 |
| 51 | MP0002272_abnormal_nervous_system | 1.36045436 |
| 52 | MP0002163_abnormal_gland_morphology | 1.33056119 |
| 53 | MP0005646_abnormal_pituitary_gland | 1.32328512 |
| 54 | MP0004381_abnormal_hair_follicle | 1.30370093 |
| 55 | MP0002420_abnormal_adaptive_immunity | 1.28567034 |
| 56 | MP0008058_abnormal_DNA_repair | 1.27751995 |
| 57 | MP0001819_abnormal_immune_cell | 1.27281399 |
| 58 | MP0003634_abnormal_glial_cell | 1.25389073 |
| 59 | MP0005451_abnormal_body_composition | 1.25169569 |
| 60 | MP0009046_muscle_twitch | 1.23695247 |
| 61 | MP0003136_yellow_coat_color | 1.21874869 |
| 62 | MP0005464_abnormal_platelet_physiology | 1.20877543 |
| 63 | MP0005332_abnormal_amino_acid | 1.20476356 |
| 64 | MP0001542_abnormal_bone_strength | 1.20001551 |
| 65 | MP0001661_extended_life_span | 1.18548498 |
| 66 | MP0001346_abnormal_lacrimal_gland | 1.18021095 |
| 67 | MP0005503_abnormal_tendon_morphology | 1.17888698 |
| 68 | MP0008877_abnormal_DNA_methylation | 1.16956569 |
| 69 | MP0010386_abnormal_urinary_bladder | 1.16616156 |
| 70 | MP0008995_early_reproductive_senescence | 1.16474670 |
| 71 | MP0001984_abnormal_olfaction | 1.16253319 |
| 72 | MP0002006_tumorigenesis | 1.14469501 |
| 73 | MP0005636_abnormal_mineral_homeostasis | 1.13067803 |
| 74 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.12401667 |
| 75 | MP0001845_abnormal_inflammatory_respons | 1.12136344 |
| 76 | MP0002736_abnormal_nociception_after | 1.11293686 |
| 77 | MP0006035_abnormal_mitochondrial_morpho | 1.09038204 |
| 78 | MP0002837_dystrophic_cardiac_calcinosis | 1.08627319 |
| 79 | MP0002933_joint_inflammation | 1.08482463 |
| 80 | MP0002064_seizures | 1.08451840 |
| 81 | MP0004134_abnormal_chest_morphology | 1.08101998 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 1.07807608 |
| 83 | MP0005253_abnormal_eye_physiology | 1.06556930 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 1.05904392 |
| 85 | MP0001545_abnormal_hematopoietic_system | 1.05904392 |
| 86 | MP0008872_abnormal_physiological_respon | 1.05775830 |
| 87 | MP0008260_abnormal_autophagy | 1.05058148 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 1.04807385 |
| 89 | MP0000689_abnormal_spleen_morphology | 1.04533232 |
| 90 | MP0004742_abnormal_vestibular_system | 1.04358356 |
| 91 | MP0003252_abnormal_bile_duct | 1.04199647 |
| 92 | MP0001188_hyperpigmentation | 1.03771528 |
| 93 | MP0002229_neurodegeneration | 1.02641897 |
| 94 | MP0005174_abnormal_tail_pigmentation | 1.02418330 |
| 95 | MP0005410_abnormal_fertilization | 1.01649616 |
| 96 | MP0002693_abnormal_pancreas_physiology | 1.01246147 |
| 97 | MP0005551_abnormal_eye_electrophysiolog | 1.01094119 |
| 98 | MP0005671_abnormal_response_to | 1.00677982 |
| 99 | MP0005379_endocrine/exocrine_gland_phen | 0.99822067 |
| 100 | MP0000013_abnormal_adipose_tissue | 0.96812652 |
| 101 | MP0002822_catalepsy | 0.96718127 |
| 102 | MP0005000_abnormal_immune_tolerance | 0.96115455 |
| 103 | MP0000465_gastrointestinal_hemorrhage | 0.95729804 |
| 104 | MP0000716_abnormal_immune_system | 0.94401821 |
| 105 | MP0002938_white_spotting | 0.93879789 |
| 106 | MP0005365_abnormal_bile_salt | 0.93620685 |
| 107 | MP0003436_decreased_susceptibility_to | 0.93456984 |
| 108 | MP0010155_abnormal_intestine_physiology | 0.93308549 |
| 109 | MP0005389_reproductive_system_phenotype | 0.91371028 |
| 110 | MP0001835_abnormal_antigen_presentation | 0.90275546 |
| 111 | MP0003866_abnormal_defecation | 0.89988654 |
| 112 | MP0001873_stomach_inflammation | 0.89344068 |
| 113 | MP0000569_abnormal_digit_pigmentation | 0.88603285 |
| 114 | MP0002419_abnormal_innate_immunity | 0.88479210 |
| 115 | MP0002405_respiratory_system_inflammati | 0.88474364 |
| 116 | MP0001764_abnormal_homeostasis | 0.88412898 |
| 117 | MP0009333_abnormal_splenocyte_physiolog | 0.87967404 |
| 118 | MP0002398_abnormal_bone_marrow | 0.87708985 |
| 119 | MP0006276_abnormal_autonomic_nervous | 0.87413216 |
| 120 | MP0003011_delayed_dark_adaptation | 0.87368678 |
| 121 | MP0009384_cardiac_valve_regurgitation | 0.87268340 |
| 122 | MP0005535_abnormal_body_temperature | 0.87235772 |
| 123 | MP0005025_abnormal_response_to | 0.87207621 |
| 124 | MP0005085_abnormal_gallbladder_physiolo | 0.87084742 |
| 125 | MP0004270_analgesia | 0.86974294 |
| 126 | MP0003763_abnormal_thymus_physiology | 0.86368860 |
| 127 | MP0004036_abnormal_muscle_relaxation | 0.86298790 |
| 128 | MP0009745_abnormal_behavioral_response | 0.84999346 |
| 129 | MP0000685_abnormal_immune_system | 0.84251131 |
| 130 | MP0001919_abnormal_reproductive_system | 0.83516290 |
| 131 | MP0005360_urolithiasis | 0.83497495 |
| 132 | MP0001756_abnormal_urination | 0.82418938 |
| 133 | MP0000681_abnormal_thyroid_gland | 0.81814468 |
| 134 | MP0000343_altered_response_to | 0.80528180 |
| 135 | MP0002734_abnormal_mechanical_nocicepti | 0.79956256 |
| 136 | MP0002095_abnormal_skin_pigmentation | 0.79840343 |
| 137 | MP0001348_abnormal_lacrimal_gland | 0.79812354 |
| 138 | MP0005075_abnormal_melanosome_morpholog | 0.78990944 |
| 139 | MP0005164_abnormal_response_to | 0.78469794 |
| 140 | MP0001666_abnormal_nutrient_absorption | 0.78200199 |
| 141 | MP0003632_abnormal_nervous_system | 0.77551892 |
| 142 | MP0002638_abnormal_pupillary_reflex | 0.76025333 |
| 143 | MP0000749_muscle_degeneration | 0.74989597 |
| 144 | MP0005387_immune_system_phenotype | 0.72801061 |
| 145 | MP0001790_abnormal_immune_system | 0.72801061 |
| 146 | MP0001664_abnormal_digestion | 0.71922367 |
| 147 | MP0000015_abnormal_ear_pigmentation | 0.71203435 |
| 148 | MP0001851_eye_inflammation | 0.70454322 |
| 149 | MP0000230_abnormal_systemic_arterial | 0.70253189 |
| 150 | MP0001485_abnormal_pinna_reflex | 0.70050570 |
| 151 | MP0001970_abnormal_pain_threshold | 0.69935659 |
| 152 | MP0008469_abnormal_protein_level | 0.67241643 |
| 153 | MP0001486_abnormal_startle_reflex | 0.67156552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.77134753 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.22555617 |
| 3 | Mitochondrial inheritance (HP:0001427) | 5.02535108 |
| 4 | Acute encephalopathy (HP:0006846) | 4.86308376 |
| 5 | Increased serum pyruvate (HP:0003542) | 4.72146907 |
| 6 | Abnormality of glycolysis (HP:0004366) | 4.72146907 |
| 7 | Progressive macrocephaly (HP:0004481) | 4.70982376 |
| 8 | Hepatocellular necrosis (HP:0001404) | 4.65761260 |
| 9 | Hepatic necrosis (HP:0002605) | 4.30510250 |
| 10 | Increased CSF lactate (HP:0002490) | 4.27724618 |
| 11 | Renal Fanconi syndrome (HP:0001994) | 4.14147122 |
| 12 | Parakeratosis (HP:0001036) | 4.11440258 |
| 13 | 3-Methylglutaconic aciduria (HP:0003535) | 4.11156641 |
| 14 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.70454770 |
| 15 | Cerebral edema (HP:0002181) | 3.60577551 |
| 16 | Increased hepatocellular lipid droplets (HP:0006565) | 3.58634040 |
| 17 | Neurofibrillary tangles (HP:0002185) | 3.55765308 |
| 18 | Leukodystrophy (HP:0002415) | 3.55467632 |
| 19 | Lipid accumulation in hepatocytes (HP:0006561) | 3.41080989 |
| 20 | Respiratory failure (HP:0002878) | 3.20115310 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.11495317 |
| 22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.95590545 |
| 23 | Lactic acidosis (HP:0003128) | 2.92560833 |
| 24 | Optic disc pallor (HP:0000543) | 2.88237459 |
| 25 | Increased intramyocellular lipid droplets (HP:0012240) | 2.87891083 |
| 26 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.80999896 |
| 27 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.79297774 |
| 28 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.79297774 |
| 29 | Hyperventilation (HP:0002883) | 2.78212020 |
| 30 | Methylmalonic acidemia (HP:0002912) | 2.76564863 |
| 31 | Thyroiditis (HP:0100646) | 2.75544598 |
| 32 | Abnormality of renal resorption (HP:0011038) | 2.73781530 |
| 33 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.70917908 |
| 34 | Abnormality of the prostate (HP:0008775) | 2.66624328 |
| 35 | Sensory axonal neuropathy (HP:0003390) | 2.66308119 |
| 36 | Molar tooth sign on MRI (HP:0002419) | 2.66216683 |
| 37 | Abnormality of midbrain morphology (HP:0002418) | 2.66216683 |
| 38 | Increased serum lactate (HP:0002151) | 2.63940443 |
| 39 | Exercise intolerance (HP:0003546) | 2.61870580 |
| 40 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.61212821 |
| 41 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.61212821 |
| 42 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.60557710 |
| 43 | Cerebral hemorrhage (HP:0001342) | 2.60133527 |
| 44 | Severe combined immunodeficiency (HP:0004430) | 2.59346246 |
| 45 | Retinal dysplasia (HP:0007973) | 2.58302417 |
| 46 | Increased muscle lipid content (HP:0009058) | 2.58293405 |
| 47 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.56964645 |
| 48 | Neuroendocrine neoplasm (HP:0100634) | 2.55170017 |
| 49 | Stomatitis (HP:0010280) | 2.54394399 |
| 50 | Vacuolated lymphocytes (HP:0001922) | 2.51545204 |
| 51 | Abnormality of B cell number (HP:0010975) | 2.51526073 |
| 52 | Exertional dyspnea (HP:0002875) | 2.49078309 |
| 53 | Hypoproteinemia (HP:0003075) | 2.43328127 |
| 54 | Renal cortical cysts (HP:0000803) | 2.42215997 |
| 55 | Methylmalonic aciduria (HP:0012120) | 2.33386706 |
| 56 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.32228962 |
| 57 | Ketoacidosis (HP:0001993) | 2.32151515 |
| 58 | Panhypogammaglobulinemia (HP:0003139) | 2.32098707 |
| 59 | Abnormal gallbladder physiology (HP:0012438) | 2.29820826 |
| 60 | Cholecystitis (HP:0001082) | 2.29820826 |
| 61 | B lymphocytopenia (HP:0010976) | 2.28984957 |
| 62 | Cerebral inclusion bodies (HP:0100314) | 2.27357013 |
| 63 | X-linked dominant inheritance (HP:0001423) | 2.25539528 |
| 64 | Abnormality of urine glucose concentration (HP:0011016) | 2.23353602 |
| 65 | Glycosuria (HP:0003076) | 2.23353602 |
| 66 | Hypothermia (HP:0002045) | 2.22402560 |
| 67 | Pancreatic cysts (HP:0001737) | 2.19388867 |
| 68 | CNS demyelination (HP:0007305) | 2.18142061 |
| 69 | Spastic paraparesis (HP:0002313) | 2.16697088 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.15943873 |
| 71 | Pheochromocytoma (HP:0002666) | 2.14503516 |
| 72 | Aplastic anemia (HP:0001915) | 2.14266201 |
| 73 | Steatorrhea (HP:0002570) | 2.12739620 |
| 74 | Generalized aminoaciduria (HP:0002909) | 2.09550867 |
| 75 | Progressive microcephaly (HP:0000253) | 2.08444259 |
| 76 | Lethargy (HP:0001254) | 2.08188477 |
| 77 | Patchy hypopigmentation of hair (HP:0011365) | 2.08103439 |
| 78 | IgG deficiency (HP:0004315) | 2.07943274 |
| 79 | Congenital primary aphakia (HP:0007707) | 2.06046434 |
| 80 | Constricted visual fields (HP:0001133) | 2.03967010 |
| 81 | Gait imbalance (HP:0002141) | 2.03467584 |
| 82 | Abolished electroretinogram (ERG) (HP:0000550) | 2.01170536 |
| 83 | Nephronophthisis (HP:0000090) | 1.98575716 |
| 84 | Respiratory difficulties (HP:0002880) | 1.97778467 |
| 85 | Cerebral hypomyelination (HP:0006808) | 1.97313198 |
| 86 | Abnormality of the renal cortex (HP:0011035) | 1.96675701 |
| 87 | Nephrogenic diabetes insipidus (HP:0009806) | 1.96294228 |
| 88 | Ketosis (HP:0001946) | 1.93131304 |
| 89 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.93053272 |
| 90 | Agammaglobulinemia (HP:0004432) | 1.92792658 |
| 91 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.92120436 |
| 92 | Abnormality of magnesium homeostasis (HP:0004921) | 1.91184172 |
| 93 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.89931997 |
| 94 | Recurrent cutaneous fungal infections (HP:0011370) | 1.89931997 |
| 95 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.89800259 |
| 96 | Dicarboxylic aciduria (HP:0003215) | 1.89800259 |
| 97 | Autoamputation (HP:0001218) | 1.89574295 |
| 98 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.89231710 |
| 99 | Hyperphosphaturia (HP:0003109) | 1.87101390 |
| 100 | Hypobetalipoproteinemia (HP:0003563) | 1.86994162 |
| 101 | Chronic diarrhea (HP:0002028) | 1.84991704 |
| 102 | Congenital stationary night blindness (HP:0007642) | 1.84901162 |
| 103 | Pulmonary fibrosis (HP:0002206) | 1.83450812 |
| 104 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.83203370 |
| 105 | Vomiting (HP:0002013) | 1.81580318 |
| 106 | Combined immunodeficiency (HP:0005387) | 1.80476907 |
| 107 | Attenuation of retinal blood vessels (HP:0007843) | 1.77603837 |
| 108 | Purpura (HP:0000979) | 1.76846880 |
| 109 | Abnormality of T cell physiology (HP:0011840) | 1.76328665 |
| 110 | Abnormality of vitamin B metabolism (HP:0004340) | 1.76298528 |
| 111 | Stridor (HP:0010307) | 1.76295549 |
| 112 | Neutropenia (HP:0001875) | 1.76123320 |
| 113 | Hypoplasia of the uterus (HP:0000013) | 1.75570829 |
| 114 | True hermaphroditism (HP:0010459) | 1.75380514 |
| 115 | Medial flaring of the eyebrow (HP:0010747) | 1.74837379 |
| 116 | Pancreatic fibrosis (HP:0100732) | 1.73878793 |
| 117 | Recurrent fungal infections (HP:0002841) | 1.73553990 |
| 118 | Abnormality of placental membranes (HP:0011409) | 1.72748003 |
| 119 | Amniotic constriction ring (HP:0009775) | 1.72748003 |
| 120 | Type I transferrin isoform profile (HP:0003642) | 1.69911414 |
| 121 | Akinesia (HP:0002304) | 1.68143150 |
| 122 | Fat malabsorption (HP:0002630) | 1.66992282 |
| 123 | Chronic obstructive pulmonary disease (HP:0006510) | 1.66442210 |
| 124 | Obstructive lung disease (HP:0006536) | 1.66442210 |
| 125 | Infantile muscular hypotonia (HP:0008947) | 1.66073956 |
| 126 | Type 2 muscle fiber atrophy (HP:0003554) | 1.65961340 |
| 127 | Abnormality of alanine metabolism (HP:0010916) | 1.65526982 |
| 128 | Hyperalaninemia (HP:0003348) | 1.65526982 |
| 129 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.65526982 |
| 130 | Large for gestational age (HP:0001520) | 1.65142443 |
| 131 | Decreased central vision (HP:0007663) | 1.64318884 |
| 132 | Renal tubular dysfunction (HP:0000124) | 1.64044762 |
| 133 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.63787736 |
| 134 | Cerebral palsy (HP:0100021) | 1.63625007 |
| 135 | Abnormality of methionine metabolism (HP:0010901) | 1.61458502 |
| 136 | Microvesicular hepatic steatosis (HP:0001414) | 1.61190592 |
| 137 | Abnormal pupillary function (HP:0007686) | 1.60519141 |
| 138 | White forelock (HP:0002211) | 1.60387818 |
| 139 | Hypoplastic pelvis (HP:0008839) | 1.59882044 |
| 140 | Metaphyseal dysplasia (HP:0100255) | 1.59779808 |
| 141 | Emotional lability (HP:0000712) | 1.59486055 |
| 142 | Split foot (HP:0001839) | 1.57588716 |
| 143 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.57168151 |
| 144 | Abnormal urine phosphate concentration (HP:0012599) | 1.55762454 |
| 145 | Erythroderma (HP:0001019) | 1.55538731 |
| 146 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.55485351 |
| 147 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.55485351 |
| 148 | Abnormal protein glycosylation (HP:0012346) | 1.55485351 |
| 149 | Abnormal glycosylation (HP:0012345) | 1.55485351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 3.94987566 |
| 2 | FRK | 3.57457121 |
| 3 | PBK | 3.52603564 |
| 4 | OXSR1 | 3.31241194 |
| 5 | TAOK3 | 3.16821376 |
| 6 | MST4 | 3.09706083 |
| 7 | MAP4K2 | 2.85405278 |
| 8 | BCR | 2.84641452 |
| 9 | STK16 | 2.61800558 |
| 10 | TNIK | 2.61477767 |
| 11 | CDK19 | 2.50980606 |
| 12 | TESK2 | 2.50254184 |
| 13 | LIMK1 | 2.28498565 |
| 14 | NME1 | 2.20478400 |
| 15 | ERBB3 | 2.15789206 |
| 16 | MAP3K12 | 2.06823936 |
| 17 | CASK | 2.02839506 |
| 18 | TRIM28 | 1.97266234 |
| 19 | ARAF | 1.91675489 |
| 20 | WNK4 | 1.89904881 |
| 21 | NME2 | 1.82808475 |
| 22 | MAPKAPK5 | 1.78960945 |
| 23 | BMPR1B | 1.77603311 |
| 24 | NUAK1 | 1.76895091 |
| 25 | CSNK1G3 | 1.74435416 |
| 26 | BCKDK | 1.69240142 |
| 27 | MUSK | 1.58059423 |
| 28 | PINK1 | 1.55829844 |
| 29 | EPHB1 | 1.55510379 |
| 30 | PIM2 | 1.52404462 |
| 31 | MET | 1.43037665 |
| 32 | MAP2K7 | 1.38503414 |
| 33 | ITK | 1.37071790 |
| 34 | EIF2AK3 | 1.36207926 |
| 35 | MYLK | 1.35152478 |
| 36 | GRK1 | 1.32937272 |
| 37 | CSNK1A1L | 1.31806254 |
| 38 | CCNB1 | 1.31802302 |
| 39 | CDK8 | 1.28602583 |
| 40 | VRK2 | 1.27220435 |
| 41 | BMPR2 | 1.23677389 |
| 42 | CSNK1G1 | 1.21994084 |
| 43 | PKN1 | 1.21740154 |
| 44 | MAP3K4 | 1.20448243 |
| 45 | ABL2 | 1.19459980 |
| 46 | FGR | 1.19270603 |
| 47 | FLT3 | 1.18788752 |
| 48 | BUB1 | 1.17966973 |
| 49 | CSNK1G2 | 1.14909500 |
| 50 | TLK1 | 1.12759361 |
| 51 | GRK7 | 1.08054665 |
| 52 | CAMK2B | 1.07136484 |
| 53 | DYRK2 | 1.06249816 |
| 54 | INSRR | 1.05826489 |
| 55 | DAPK1 | 1.04775910 |
| 56 | ADRBK2 | 0.94334873 |
| 57 | IRAK4 | 0.91130067 |
| 58 | CAMK2D | 0.91019394 |
| 59 | RPS6KA4 | 0.89900505 |
| 60 | ROCK2 | 0.87315741 |
| 61 | MAP4K1 | 0.85505267 |
| 62 | TRPM7 | 0.84897914 |
| 63 | SIK3 | 0.83340228 |
| 64 | KIT | 0.82429904 |
| 65 | EIF2AK1 | 0.82019541 |
| 66 | PRKCQ | 0.80401149 |
| 67 | SCYL2 | 0.79245958 |
| 68 | MAP2K6 | 0.77707348 |
| 69 | WNK3 | 0.77401026 |
| 70 | VRK1 | 0.76058409 |
| 71 | PLK2 | 0.76025887 |
| 72 | CAMK2G | 0.74830595 |
| 73 | MAPK13 | 0.74806202 |
| 74 | MINK1 | 0.73808087 |
| 75 | PRKCE | 0.72969876 |
| 76 | TESK1 | 0.72621537 |
| 77 | NEK6 | 0.69756113 |
| 78 | EPHA4 | 0.69073862 |
| 79 | PDK2 | 0.68896767 |
| 80 | PIK3CA | 0.68778535 |
| 81 | CAMK2A | 0.68745274 |
| 82 | BTK | 0.68226098 |
| 83 | PIK3CG | 0.67020080 |
| 84 | ERBB4 | 0.63181511 |
| 85 | MOS | 0.62251630 |
| 86 | DAPK2 | 0.61709095 |
| 87 | MAP3K14 | 0.61130080 |
| 88 | WNK1 | 0.59972639 |
| 89 | GRK6 | 0.58850276 |
| 90 | GRK5 | 0.58825336 |
| 91 | TXK | 0.58685971 |
| 92 | KDR | 0.58082843 |
| 93 | ABL1 | 0.57748184 |
| 94 | RPS6KA5 | 0.57195758 |
| 95 | UHMK1 | 0.56566465 |
| 96 | IRAK2 | 0.56490413 |
| 97 | TBK1 | 0.56127824 |
| 98 | CDK14 | 0.56009896 |
| 99 | ADRBK1 | 0.54096801 |
| 100 | SRPK1 | 0.53828818 |
| 101 | MST1R | 0.52486576 |
| 102 | DAPK3 | 0.52410674 |
| 103 | BRAF | 0.51650372 |
| 104 | FGFR2 | 0.51206135 |
| 105 | MAPKAPK3 | 0.49233127 |
| 106 | PRPF4B | 0.48976194 |
| 107 | IGF1R | 0.48223423 |
| 108 | LYN | 0.46803020 |
| 109 | PAK3 | 0.46678128 |
| 110 | IRAK1 | 0.46142114 |
| 111 | OBSCN | 0.45272671 |
| 112 | TYK2 | 0.45254444 |
| 113 | PTK2B | 0.44864366 |
| 114 | FES | 0.44462113 |
| 115 | BLK | 0.44196198 |
| 116 | MAP3K5 | 0.44131462 |
| 117 | TEC | 0.43451110 |
| 118 | CSF1R | 0.41799072 |
| 119 | IKBKE | 0.41268756 |
| 120 | CDK18 | 0.40194630 |
| 121 | SYK | 0.40050150 |
| 122 | ZAK | 0.39504433 |
| 123 | MATK | 0.39467288 |
| 124 | PHKG1 | 0.38821522 |
| 125 | PHKG2 | 0.38821522 |
| 126 | CDK15 | 0.38474397 |
| 127 | ACVR1B | 0.38179766 |
| 128 | NTRK1 | 0.37840560 |
| 129 | CDK11A | 0.36871945 |
| 130 | PRKCD | 0.36248534 |
| 131 | LCK | 0.36075849 |
| 132 | IKBKB | 0.35897568 |
| 133 | ILK | 0.35288232 |
| 134 | MAPK15 | 0.34505952 |
| 135 | CAMKK2 | 0.34369479 |
| 136 | EIF2AK2 | 0.33958495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.01220217 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.00611005 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.99617796 |
| 4 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.30099596 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 3.23072290 |
| 6 | Alzheimers disease_Homo sapiens_hsa05010 | 3.15512292 |
| 7 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.09301518 |
| 8 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.95940632 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.95188636 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.91361457 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.68546433 |
| 12 | Huntingtons disease_Homo sapiens_hsa05016 | 2.50034823 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.25741941 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.17654944 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.98352973 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.93132656 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.80675229 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.58096703 |
| 19 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.56865026 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.53114951 |
| 21 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.47550325 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.46734250 |
| 23 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.45061805 |
| 24 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.43804156 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.43663135 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.38965965 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.38655904 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.35565798 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35009273 |
| 30 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.34908233 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.31457491 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.27730748 |
| 33 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.22900192 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.22321053 |
| 35 | Phototransduction_Homo sapiens_hsa04744 | 1.21719381 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21292584 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.19915404 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.19577637 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.16907457 |
| 40 | RNA polymerase_Homo sapiens_hsa03020 | 1.13834978 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.13603078 |
| 42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.11870779 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.08994766 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03737083 |
| 45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.01007350 |
| 46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.94103660 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 0.93613136 |
| 48 | RNA degradation_Homo sapiens_hsa03018 | 0.91042868 |
| 49 | Metabolic pathways_Homo sapiens_hsa01100 | 0.90200020 |
| 50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.87714018 |
| 51 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.87416153 |
| 52 | Leishmaniasis_Homo sapiens_hsa05140 | 0.86698304 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.84683250 |
| 54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82015119 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81960416 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81495870 |
| 57 | Allograft rejection_Homo sapiens_hsa05330 | 0.79210050 |
| 58 | Homologous recombination_Homo sapiens_hsa03440 | 0.78452475 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.77724062 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76731438 |
| 61 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.75370713 |
| 62 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74159769 |
| 63 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71588436 |
| 64 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.71396872 |
| 65 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70912013 |
| 66 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.70623926 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67146411 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66582861 |
| 69 | Malaria_Homo sapiens_hsa05144 | 0.64459407 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63976370 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62730537 |
| 72 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.62403980 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59998623 |
| 74 | Legionellosis_Homo sapiens_hsa05134 | 0.59544745 |
| 75 | Base excision repair_Homo sapiens_hsa03410 | 0.56947904 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55539648 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54970262 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.54609458 |
| 79 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54492893 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52704639 |
| 81 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52327181 |
| 82 | Tuberculosis_Homo sapiens_hsa05152 | 0.50785257 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.49391328 |
| 84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47525918 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46741169 |
| 86 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.43845388 |
| 87 | Carbon metabolism_Homo sapiens_hsa01200 | 0.43021835 |
| 88 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43015769 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42535911 |
| 90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42027388 |
| 91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.41687167 |
| 92 | Shigellosis_Homo sapiens_hsa05131 | 0.40871630 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38615097 |
| 94 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38613142 |
| 95 | Asthma_Homo sapiens_hsa05310 | 0.38426396 |
| 96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35604344 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | 0.35580651 |
| 98 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35091581 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.31858075 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.31414722 |
| 101 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.31149665 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30012723 |
| 103 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.29764533 |
| 104 | Purine metabolism_Homo sapiens_hsa00230 | 0.28779439 |
| 105 | Salivary secretion_Homo sapiens_hsa04970 | 0.28101593 |
| 106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.28081036 |
| 107 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.27799491 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.27439300 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.25932782 |
| 110 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.25766225 |
| 111 | Pertussis_Homo sapiens_hsa05133 | 0.25475656 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25315437 |
| 113 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.24323124 |
| 114 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23590161 |
| 115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.23416977 |
| 116 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.19122195 |
| 117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.13908805 |
| 118 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.13517228 |
| 119 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.13416880 |
| 120 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.13027935 |
| 121 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.12710457 |
| 122 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.12377897 |
| 123 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.11252775 |
| 124 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.11145072 |
| 125 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.10535849 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.07018890 |

